Zunyi Medical University

University / College


Location: Guizhou, China (CN) CN

ISNI: 0000000102406969

ROR: https://ror.org/00g5b0g93

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

β-catenin is a Potential Prognostic Biomarker in Uterine Sarcoma (2025) Cai Y, Wang Y, Yang L, Huang Y, Chen MJ, Zhang C, Jin SH, et al. Journal article Efficacy of radiotherapy combined with atezolizumab or docetaxel in patients with previously treated NSCLC (2024) Xu J, Wang H, Zhang C, Jin SH, Chen X, Tan F, Frey B, et al. Journal article Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny (2024) Li S, Peng Y, Chen M, Zhao Y, Xiong Y, Li J, Luo P, et al. Journal article Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy (2024) Zhou JG, Yang J, Wang H, Wong AHH, Tan F, Chen X, He SS, et al. Journal article TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy (2024) Wang S, Xiong Y, Zhang Y, Wang H, Chen M, Li J, Luo P, et al. Journal article Positive response to trastuzumab deruxtecan in a patient with HER2-mutant NSCLC after multiple lines therapy, including T-DM1: a case report. (2024) Xu J, He B, Wang Y, Wu M, Lu Y, Su Z, Liu S, et al. Journal article Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma (2024) Miao Y, Dong M, Zhou Q, Thiel J, Li N, Cai Y, Yuan D, et al. Journal article Comprehensive Analysis of Non-coding RNAs Expression Profile and miRNA- circRNA-gene Co-expression Network in Developing Uterine Carcinosarcoma (2024) Chen MJ, Yang L, Huang Y, Wang Y, Cai Y, Zhang C, Jin SH, et al. Journal article Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent international studies (2023) Zhou JG, Liang R, Wang HT, Jin SH, Hu W, Frey B, Fietkau R, et al. Journal article Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice (2022) Ma SC, Bai X, Guo XJ, Liu L, Xiao LS, Lin Y, Tan JL, et al. Journal article
1 2 3 4